Form 8-K - Current report:
SEC Accession No. 0000950170-23-044892
Filing Date
2023-08-29
Accepted
2023-08-29 08:06:16
Documents
16
Period of Report
2023-08-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dna-20230829.htm   iXBRL 8-K 77217
2 EX-99.1 dna-ex99_1.htm EX-99.1 36522
3 GRAPHIC img197909486_0.jpg GRAPHIC 10277
4 GRAPHIC img197909486_1.jpg GRAPHIC 6439
  Complete submission text file 0000950170-23-044892.txt   307033

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dna-20230829.xsd EX-101.SCH 3381
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dna-20230829_pre.xml EX-101.PRE 14390
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dna-20230829_lab.xml EX-101.LAB 22641
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dna-20230829_def.xml EX-101.DEF 14224
10 EXTRACTED XBRL INSTANCE DOCUMENT dna-20230829_htm.xml XML 6374
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 231218166
SIC: 2836 Biological Products, (No Diagnostic Substances)